LAMB3 and prostate cancer: The results demonstrated that both in the LNCaP cell line and PC3 cell line, the invasion capacity of the knockdown group (Sh-LAMB3) still showed significant changes compared to the control group (Sh-Ctrl), Conversely, the invasion ability of prostate cancer cells decreased significantly after LAMB3 overexpression.